Home / Science / New Antibiotic Design Fights Superbugs
New Antibiotic Design Fights Superbugs
29 May
Summary
- Scientists created a new method to design antibiotics against resistant infections.
- This approach can develop new treatments and revive existing, less effective drugs.
- Antibiotic resistance causes over 1.27 million deaths annually worldwide.
A groundbreaking approach to antibiotic design has been developed, offering a new weapon against drug-resistant infections. Researchers have introduced the 'Efflux Resistance Breaker' (ERB) strategy, aimed at circumventing common bacterial defense mechanisms.
This innovative method holds the potential to accelerate the development of entirely new antibiotics. Furthermore, it could restore the effectiveness of existing antibiotic classes that have become less potent over time as bacteria evolve resistance.
Antibiotic resistance poses a severe global health crisis, with the World Health Organization estimating it causes about 1.27 million deaths annually. The misuse and overuse of antibiotics contribute to this growing threat, making infections harder to treat and medical procedures riskier.
The ERB approach specifically targets efflux pumps, molecular mechanisms bacteria use to expel antibiotics from their cells before they can be effective. By chemically redesigning antibiotics to resist these pumps, their ability to kill resistant bacteria is restored.
